News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<Research>CCBI Adds NTES-S TP to HKD226.2; Momentum Back on Track
NTES-S (09999.HK) delivered a solid, better-than-expected performance in 1Q25, CCBI wrote in its research report.Looking ahead, CCBI expected the momentum in NTES-S' gaming bus...
Reset
Send
The window will close in 5 seconds
<Research>CCBI Adds NTES-S TP to HKD226.2; Momentum Back on Track
Close
Recommend
4
Positive
3
Negative
4
 
SHORT SELL
 
STOCK INFO

NTES-S (09999.HK)  -2.300 (-1.207%)    Short selling $173.39M; Ratio 16.218%   delivered a solid, better-than-expected performance in 1Q25, CCBI wrote in its research report.

Looking ahead, CCBI expected the momentum in NTES-S' gaming business to persist after considering a lower base for its mobile games starting from 2Q25, the ongoing strong performance of its recent titles such as "Marvel Rivals", "Where Winds Meet", and "Once Human", and greater resilience demonstrated by its long-lasting games.

Related NewsCICC Lists Changes in HSI Constituents' Weightings, Forecasts in Passive Funds Changes (Table)
The broker also anticipated NTES-S to maintain healthy profit margins given its prudent marketing strategy and focused efforts in scaling back unprofitable non-gaming businesses.

CCBI raised its target price for NTES-S from HKD184.6 to HKD226.2. For its US stocks, the broker also lifted its target price from USD118.3 to USD145. Both were given an unchanged Outperform rating.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-05-21 16:25.)

AAStocks Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.